Yasuyuki Kawamoto
机构:Hokkaido University, Hokkaido University Hospital, Daido University · ORCID:0000-0002-7706-0015
发表论文 228 篇 · 总被引 2051 次 · h-index 18
代表论文
- Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial (2024 · Journal of Clinical Oncology · 被引 63)
- Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer (2023 · British Journal of Cancer · 被引 34)
- The Short- and Long-Term Surgical Results of Consecutive Hepatopancreaticoduodenectomy for Wide-Spread Biliary Malignancy (2023 · Annals of Surgical Oncology · 被引 10)
- Circulating tumor DNA (ctDNA) analyses in patients with HER2-positive biliary tract cancer (BTC) treated with trastuzumab deruxtecan (T-DXd): Exploratory results from the HERB trial. (2023 · Journal of Clinical Oncology · 被引 10)
- Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101) (2023 · Journal of Clinical Medicine · 被引 9)
- Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer (2024 · British Journal of Cancer · 被引 8)